Ardent Health (ARDT) EBITDA Margin: 2022-2024
Historic EBITDA Margin for Ardent Health (ARDT) over the last 3 years, with FY2024 value amounting to 11.23%.
- Ardent Health's EBITDA Margin fell 42000.0% to 17.64% in Q3 2025 from the same period last year, while for Sep 2025 it was 11.2%, marking a year-over-year increase of 30700.0%. This contributed to the annual value of 11.23% for FY2024, which is 43300.0% up from last year.
- Latest data reveals that Ardent Health reported EBITDA Margin of 11.23% as of FY2024, which was up 43300.0% from 15.56% recorded in FY2023.
- Over the past 5 years, Ardent Health's EBITDA Margin peaked at 11.23% during FY2024, and registered a low of 15.56% during FY2023.
- Over the past 3 years, Ardent Health's median EBITDA Margin value was 12.55% (recorded in 2022), while the average stood at 13.11%.
- Per our database at Business Quant, Ardent Health's EBITDA Margin plummeted by -30100bps in 2023 and then skyrocketed by 43300bps in 2024.
- Annual analysis of 3 years shows Ardent Health's EBITDA Margin stood at 12.55% in 2022, then fell by -24bps to 15.56% in 2023, then grew by 28bps to 11.23% in 2024.
- Its EBITDA Margin stands at 11.23% for FY2024, versus 15.56% for FY2023 and 12.55% for FY2022.